NewGenIvf (NIVF) Equity Average (2023 - 2025)
NewGenIvf (NIVF) has disclosed Equity Average for 3 consecutive years, with $12.8 million as the latest value for Q4 2025.
- Quarterly Equity Average rose 1064.48% to $12.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.8 million through Dec 2025, up 1064.48% year-over-year, with the annual reading at $12.8 million for FY2025, 1064.48% up from the prior year.
- Equity Average for Q4 2025 was $12.8 million at NewGenIvf, up from $1.1 million in the prior quarter.
- The five-year high for Equity Average was $12.8 million in Q4 2025, with the low at $1.1 million in Q4 2024.
- Average Equity Average over 3 years is $5.2 million, with a median of $1.7 million recorded in 2023.
- The sharpest move saw Equity Average tumbled 34.35% in 2024, then skyrocketed 1064.48% in 2025.
- Over 3 years, Equity Average stood at $1.7 million in 2023, then plummeted by 34.35% to $1.1 million in 2024, then surged by 1064.48% to $12.8 million in 2025.
- According to Business Quant data, Equity Average over the past three periods came in at $12.8 million, $1.1 million, and $1.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.